Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Myeloid | 2 | 2021 | 11 | 1.340 |
Why?
|
| Cytodiagnosis | 2 | 2021 | 20 | 0.750 |
Why?
|
| Pleural Effusion | 1 | 2021 | 74 | 0.730 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 37 | 0.710 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2020 | 76 | 0.710 |
Why?
|
| Dendritic Cells | 1 | 2020 | 201 | 0.640 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2017 | 300 | 0.590 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2016 | 5 | 0.570 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 375 | 0.530 |
Why?
|
| Liver | 1 | 2020 | 1118 | 0.490 |
Why?
|
| Melanoma | 1 | 2016 | 335 | 0.410 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 1140 | 0.320 |
Why?
|
| Kidney Neoplasms | 2 | 2018 | 206 | 0.260 |
Why?
|
| Neoplasms | 1 | 2016 | 1667 | 0.250 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 508 | 0.240 |
Why?
|
| Cerebellar Neoplasms | 1 | 2022 | 17 | 0.210 |
Why?
|
| Medulloblastoma | 1 | 2022 | 24 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2020 | 4 | 0.180 |
Why?
|
| Penile Induration | 1 | 2020 | 2 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2020 | 23 | 0.180 |
Why?
|
| Middle Aged | 9 | 2021 | 21147 | 0.180 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 11 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2020 | 18 | 0.180 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 40 | 0.180 |
Why?
|
| Prognosis | 3 | 2020 | 2093 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2021 | 168 | 0.180 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 8 | 0.180 |
Why?
|
| Penis | 1 | 2020 | 25 | 0.180 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 19 | 0.180 |
Why?
|
| Translocation, Genetic | 1 | 2020 | 74 | 0.180 |
Why?
|
| Humans | 14 | 2022 | 68618 | 0.180 |
Why?
|
| Eosinophilia | 1 | 2020 | 47 | 0.180 |
Why?
|
| Ossification, Heterotopic | 1 | 2020 | 45 | 0.180 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 33 | 0.180 |
Why?
|
| Pancreas | 1 | 2021 | 225 | 0.170 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 70 | 0.170 |
Why?
|
| Polyomavirus | 1 | 2018 | 4 | 0.160 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 371 | 0.160 |
Why?
|
| Squamous Intraepithelial Lesions of the Cervix | 1 | 2017 | 4 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 332 | 0.150 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 66 | 0.150 |
Why?
|
| Skin | 1 | 2020 | 451 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 138 | 0.140 |
Why?
|
| Papanicolaou Test | 1 | 2017 | 54 | 0.140 |
Why?
|
| Vaginal Smears | 1 | 2017 | 79 | 0.140 |
Why?
|
| Fixatives | 1 | 2016 | 24 | 0.140 |
Why?
|
| Male | 9 | 2021 | 37321 | 0.140 |
Why?
|
| Formaldehyde | 1 | 2016 | 48 | 0.140 |
Why?
|
| Carcinoma | 1 | 2018 | 215 | 0.140 |
Why?
|
| Carcinoma, Papillary | 1 | 2016 | 35 | 0.130 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 110 | 0.130 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 194 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 300 | 0.120 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2014 | 18 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 468 | 0.120 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 28 | 0.120 |
Why?
|
| Proteins | 1 | 2018 | 474 | 0.120 |
Why?
|
| Hand | 1 | 2014 | 90 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2016 | 431 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1173 | 0.100 |
Why?
|
| Mass Screening | 1 | 2017 | 843 | 0.100 |
Why?
|
| Adult | 5 | 2020 | 21403 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 629 | 0.080 |
Why?
|
| Female | 6 | 2020 | 38074 | 0.070 |
Why?
|
| Animals | 1 | 2020 | 20881 | 0.050 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2022 | 13 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2022 | 20 | 0.050 |
Why?
|
| Aged | 4 | 2020 | 14862 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 38 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2020 | 7277 | 0.050 |
Why?
|
| Metaplasia | 1 | 2020 | 27 | 0.050 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 7 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2020 | 63 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2020 | 52 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 24 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 144 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 4848 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 446 | 0.040 |
Why?
|
| Genomics | 1 | 2020 | 168 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2020 | 159 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 371 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 622 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 169 | 0.040 |
Why?
|
| United States | 2 | 2020 | 7367 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 376 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 111 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1619 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 800 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1174 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 502 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 369 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 2891 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1753 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2022 | 2689 | 0.030 |
Why?
|
| Child | 1 | 2022 | 6405 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 4655 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 3259 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 3705 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7029 | 0.020 |
Why?
|